Regulated Cannabis and Hemp Market Navigation

Business, Public Health, and Research Challenges
1. Auflage 2024
ISBN: 978-3-11-067742-3
Verlag: De Gruyter

Buch, Englisch, 172 Seiten, Format (B × H): 170 mm x 240 mm, Gewicht: 333 g

Reihe: Cannabis innovations

Embark on a transformative journey through uncharted realms of research and industry with the first book of the "Cannabis Innovations" series. This multidisciplinary effort breaks the mold of typical cannabis texts by providing chapters written by a diverse array of professionals actively shaping the frontiers of cannabis science and business. Regulatory consultants, lawyers, pharmacologists, industry operators, and academics unite to offer seldom encountered perspectives found in traditional cannabis discourse. Our compilation is a carefully curated exploration of the advanced and interconnected complexities of cannabis and is tailored for those with a foundational understanding, ready to delve deeper into the subject.

This is part of a larger DeGruyter initiative which focuses on innovative and novel topics, each volume of this series serves as a guide through the multifaceted landscape of cannabis. Step into a pragmatic view of the cannabis industry’s future, where research and innovation converge to advance our understanding of this complex plant, helping us become poised to balance the risks and benefits for the challenges that lay ahead.

Zielgruppe

Workers and decision-makers in the medical cannabis industry; stu

Autoren/Hrsg.

Marcu, Jahan

Peterson, Andrew M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizinrecht, Gesundheitsrecht
• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Rechtswissenschaften Öffentliches Recht Medizin- und Gesundheitsrecht Arzneimittelrecht und Medizinprodukterecht, Apothekenrecht, Krankenhausrecht
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie

Über Autor(innen)

Dr. Jahan Marcu Dr. Jahan Marcu has over 15 years of experience in cannabinoid research, policy, and operations. He has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system, and the role of the ECS in bone). Dr. Marcu’s work has been instrumental to facilitating and supporting fact-based, scientific approaches vital to industry and patients. This has included research focused on solving the structure and function of cannabinoid receptors, the anti-cancer properties of cannabis compounds, as well as method development and validation for analyzing complex formulations. Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia’s Cannabis Quality Control and Therapeutic Monographs, and assisting in the creation of the first standards for industry as chairman of the cannabis committee for the American Herbal Products Association (AHPA). His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu published one of the first product safety study on CBD products. He is presently the Editor-In-Chief of the American Journal of Endocannabinoid Medicine. He is the co-founder and former Chief Science Officer for the International Research Center on Cannabis and Health (aka the Cannabis Research Institute). He is also founder and past-chair of the Cannabis Chemistry Sub-division of the American Chemical Society, the world’s largest and oldest professional scientific society. Further illustrating the recognition earned through his efforts, he has been asked to serve on multiple expert government advisory and trade association committees, as well as scientific organizations including ASTM (D37 Subcommittee chair), AHPA Cannabis committee (past-chair), ACS Cannabis Chemistry Subdivision (CANN), AOCS, AOAC, IACM(past BOD), and IMCPC (co-founder). Reflecting his dedication to the field, Dr. Marcu has received numerous awards including the Mahmoud Elsohly award for excellence in cannabis chemistry and the Billy Martin research achievement award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. He is also a court-qualified synthetic cannabinoid and cannabis expert. His work has been published and covered in publications such as Science, Nature, JAMA, the Washington Post, CNN, and many other media outlets. Dr. Andrew Peterson Andrew M. Peterson PharmD, PhD, is Professor of Pharmacy at the Philadelphia College of Pharmacy, Saint Joseph’s University, Philadelphia, PA. Prior to that he served as the Executive Director of the Substance Use Disorders Institute and Professor of Clinical Pharmacy and Health Policy at University of the Sciences in Philadelphia. He previously served as Dean of the Mayes College of Healthcare Business and Policy at USciences. Highly regarded in the fields of Pharmacy Management and Health Policy, Dr. Peterson has more than 30 years’ research experience in medication compliance, health outcomes and policy research, and substance use disorders. Dr. Peterson speaks at conferences worldwide on issues related to pharmacy and health policy and is known for his commitment to mentoring others and fostering success. Active in the academic and research communities, Dr. Peterson has served on the boards of many organizations and is engaged in several professional organizations including the American Pharmacists Association, the Pennsylvania Pharmacists Association, and the International Society for Pharmacoeconomics and Outcomes Research. Dr. Peterson earned his BS in Pharmacy from Rutgers University, his PharmD from Virginia Commonwealth University and his PhD in health policy at USciences. He also completed an advanced residency in hospital pharmacy administration at Thomas Jefferson University Hospital and a residency in hospital pharmacy practice from Rush-Presbyterian St. Luke’s Medical Center.